Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Triple Negative Breast Neoplasms
×
pertuzumab
×
Clear all
Filters
3
NCT01042379
2026-03-13
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2
Recruiting
5,000 enrolled
NCT05020860
2025-02-27
RESPONSE
Baylor Breast Care Center
Phase 2
Recruiting
185 enrolled